Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Unichem Laboratories gets USFDA approval, up 4.5%

    Montelukast Sodium tablets 10mg are therapeutically equivalent to Singulair Tablets 10mg of Merck Sharp & Dohme Corp.
    October 09, 2015 / 14:44 IST

    Moneycontrol BureauShares of Unichem Laboratories 4.5 percent intraday Friday as the company has received Abbreviated New Drug Application (ANDA) approval from United States Food and Drug Administration (USFDA) for Montelukast Sodium tablets.Montelukast Sodium tablets 10mg are therapeutically equivalent to Singulair Tablets 10mg of Merck Sharp & Dohme Corp.The product will be comercialized from Unichem's Goa lab. The company now has total o19 ANDA approval from USFDA.At 14:39 hrs Unichem Laboratories was quoting at Rs 313.00, up Rs 6.80, or 2.22 percent on the BSE.Posted by Rakesh Patil

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert:

    It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347